The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review.

ABSTRACT: Tricuspid valve endocarditis (TVE) is a growing concern with increasing rates and mortality burden. The currently changing etiology, the antibiotic resistance and the raise in iatrogenic causes as with implantable cardiac devices [cardiac implantable electronic device (CIED)], represent a challenge for the management of these patients. The progressively widespread use of CIEDs is adding to the more commonly known intravenous (IV) drug abuse in the list of causes. Treatment strategies include medical therapy alone or surgery. From the surgical standpoint tricuspid valve repair, replacement or the staged procedure of valvectomy as bridge to replacement are available options. Treatment of endocarditis related to implantable device is another expanding field which requires a coordinated action

SUBMITTER: Nappi F 

PROVIDER: S-EPMC7791263 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature